Efficacy, Safety and Tolerability of KAF156 in Combination With Lumefantrine Solid Dispersion Formulation (LUM-SDF) in Pediatric Population With Uncomplicated Plasmodium Falciparum Malaria
Clinical trial NCT04546633 · COMPLETED
Trial details
- NCT number
- NCT04546633
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-16
- Primary completion
- 2024-08-13
- Enrollment
- 295
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.